InduPro Analysis: $170M Raised
What is InduPro?
InduPro develops cell-surface protein interaction technologies to create new signaling pathways and logic gates. Their platform manipulates protein pairings beyond natural biological signaling. The company focuses on advancing life-changing therapies through proximity-driven biological interventions.
Location
Seattle, United States
Employees
51-200
Founded
2022
Funding Status
Series A
Product Features & Capabilities
- Cell-surface protein proximity platform
- Induced protein proximity technology
- Novel signaling pathway design
- Logic gate creation in biological systems
Use Cases
Design signaling pathways for targeted cancer therapies; Create logic gates to control gene expression in rare diseases; Manipulate protein interactions in neurodegenerative disorders; Enable precise modulation of immune responses in autoimmune conditions; Develop therapies for metabolic disorders via spatial protein control
Other Considerations
Founded in 2022; HQ in Seattle and Cambridge; Backed by Wilson Sonsini and Euclidean Capital; Employee count 11-50
See something that needs updating? Suggest edits to this profile.